Liver transplantation as treatment for neurological disorders

References

• Mowat AR Orthotopic liver transplantation in liver based metabolic disorders. Eur Pecliatc 151(Suppl. 1), S32—S38 (1992).
   Google Scholar
• Kaneko K, Takei Y, Aoki T, Ikeda S, Matsunami H, Lynch S. Bilirubin adsorption therapy and subsequent liver transplantation cured severe bilirubin encephalopathy in a long-term survival patient with Criglerq—Najjar disease type I. Intern. Med. 39, 961–965 (2000).
   PubMed Web of Science ®Google Scholar
• Ikeda S, Hanyu N, Hongo M etaL Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain 110, 315–337 (1987).
   Google Scholar
• Andrade C. A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 110, 408–427 (1952).
   Web of Science ®Google Scholar
• Andersson R. Familial amyloidosis with polyneuropathy. Acta Med. Scam 188, 85–94 (1970).
   Google Scholar
• Araki S, Mawatari S, Ohta M, Nakajima A, Kuroiwa Y. Polyneuritic amyloidosis in a Japanese family. Arch. Neural. 18, 593–602 (1968).
   PubMed Web of Science ®Google Scholar
• Kito S, Itoga E, Kamiya K, Kishida T, Yamamura Y. Studies on familial amyloid polyneuropathy in Ogawa village, Japan. Eur. Neural. 19, 141–151 (1980).
   Google Scholar
• Connors LH, Richardson AM, Théberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/ 2000. Arnyloid. Int. .1. Exp. Clin. Invest. 7, 54–69 (2000).
   Google Scholar
• Nakazato M, Kangawa K, Minamino N, Tawara S, Matsu° H, Araki S. Radioimmunoassay for detecting abnormal prealbumin in the serum for diagnosis of familial amyloidotic polyneuropathy (Japanese type). Biochem. Biophys. Res. Commu. 122, 719–725 (1984).
   Google Scholar
• Ikeda S, Nakano T, Yanagisawa N, Nakazato M, Tsukagoshi H. Asymptomatic homozygous gene carrier in a family with type I familial amyloid polyneuropathy. Eur. Neural. 32, 308–313 (1992).
   Google Scholar
• Tachibana N, Tokuda T, Yoshida K et al. Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Arnyloid: hit.j Exp. Clin. Invest. 6, 282–288 (1999).
   Google Scholar
• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan. Clinical and genetic heterogeneity. Neurology 58, 1001–1007 (2002).
   Google Scholar
• •Describes the detailed clinical pictures of familial amyloid polyneuropathy including the widespread clinical variations.
   Google Scholar
• Misu K, Hattori N, Nagamatsu Metal Late- onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Bmin122, 1951-1962 (1999).
   Google Scholar
• Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S. Clinical and pathological studies of cardiac amyloidosis in transthyretin familial type amyloid polyneuropathy. Arnyloid I Protein Folding Disord (In Press).
   Google Scholar
• Takahashi K, Sakashita N, Ando Y, Suga M, Ando M. Late onset type I familial amyloidotic polyneuropathy: presentation of three autopsy cases in comparison with 19 autopsy cases of the ordinary type. Pathol Int. 47, 353–359 (1997).
   Google Scholar
• Nakamura Y, Yutani C, Nakazato M, Date Y, Baba T, Goto Y. A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy and the presence of giant cells. Pathol Int. 49, 898–902 (1999).
   PubMed Web of Science ®Google Scholar
• Lobato L, Beirao I, Guimaraes SM et al Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits. Am.Kidney Dis. 31, 940–946 (1998).
   PubMed Web of Science ®Google Scholar
• Garzuly F, Wisniewski T, Brirrig F, Budka H. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin ( FIR Aspl8Gly). Neurology 47, 1562–1567 (1996).
   PubMed Web of Science ®Google Scholar
• Petersen RB, Goren H, Cohen M et al. Transthyretin amyloidosis: a new mutation associated with dementia. Ann. Neural 41, 307–313 (1997).
   PubMed Web of Science ®Google Scholar
• Uemichi T, Uitti RJ, Koeppen AH, Donat JR, Benson MD. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch. Nemo'. 56, 1152–1155 (1999).
   Google Scholar
• Soprano DR, Herhert J, Soprano K, Schon E, Goodman D. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues. J. Biol. Chem. 260, 11793–11798 (1985).
   Google Scholar
• Holmgren G, Steen L, Ekstedt J et al Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Gun. Genet. 40, 242–246 (1991).
   Google Scholar
• Holmgren G, Ericzon B-G, Groth C-G et al Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341, 1113–1116 (1993).
   PubMed Web of Science ®Google Scholar
• Ericzon B-G. Familial Amyloidotic Polyneuropathy World Transplant Register (FAPWTR) and the Domino Transplant Register. Update on behalf of reporting members of the FAPWTR December (2001).
   Google Scholar
• Carvalho M de, Conceicao I, Bentes C, Luis MLS. Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (PortugueseV30M). Amyloid:j Protein Folding Disoni 9, 126–133 (2002).
   PubMed Web of Science ®Google Scholar
• Suhr OB, Holmgren G, Steen L et al Liver transplantation in familial amyloidotic polyneuropathy. Transplantation 60, 933–938 (1995).
   PubMed Web of Science ®Google Scholar
• Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transpinatation. Neumlogy47, 944–951 (1996).
   PubMed Web of Science ®Google Scholar
• Suhr OB, Wiklund U, Ando Y, Olofsson B- O. Impact of liver transplantation on autonomic neuropathy in familial amyloidotic polyneuropathy: an evaluation by spectral analysis of heart rate variability. J. Int. Merl 242, 225–229 (1997).
   Google Scholar
• Adams D, Samuel D, Goulon-Goeau C et al The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123,1495–1504 (2000).
   PubMed Web of Science ®Google Scholar
• •Describes therapeutic effects of liver transplantations for familial amyloid polyneuropathy patients by analyzing many parameters and also proposes the indication for liver transplantation in patients with this disease.
   Google Scholar
• Jonsén E, Suhr OB, Tashima K, Athlin E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid.j Protein Folding Disord 8, 52–57 (2001).
   PubMed Web of Science ®Google Scholar
• Matsunami H, Makuuchi M, Kawasaki S et al A case of familial amyloid polyneuroapthy treated with partial liver transplantation using a graft from a living related donor. Transplantation 60, 301–303 (1995).
   PubMed Web of Science ®Google Scholar
• Ikeda S, Takei Y, Yanagisawa N et al. Partial liver transplantation from living donors in familial amyloid polyneuropathy. Amyloirt Int. Exp. Clin. Invest. 4, 18–23 (1997).
   Web of Science ®Google Scholar
• Ikegami T, Kawasaki S, Ohno Y et al. Temporary auxiliary liver transplantation from a living donor to an adult recipient with familial amyloid polyneuropathy. Transplantion 73, 628–630 (2002).
   PubMed Web of Science ®Google Scholar
• Takei Y, Ikeda S, Hashikura Y, Ikegami T, Kawasaki S. Partial-liver transplantation to treat familial amyloid polyneuropathy: follow-up of 11 patients. Ann. Intern. Med131, 592–595 (1999).
   Google Scholar
• Kobayashi S, Morita H, Asawa T et al Peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation. Arnyloirli Protein Folding Disord 10, 17–24 (2003).
   PubMed Web of Science ®Google Scholar
• Owa M, Takei Y, Hashikura Y, Kawasaki S, Koyama M, Ikeda S. Recurrent cerebral embolism in a familial amyloid polyneuropathy patient who received partial liver transplantation from a living donor. Intern. Merl 40, 259–264 (2001).
   PubMed Web of Science ®Google Scholar
• Suhr OB, Ericzon B-G, Friman S. Long- term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 8, 787–794 (2002).
   Google Scholar
• Ando Y, Ando E, Tanaka Y et al. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 82, 1097–1098 (1996).
   Google Scholar
• Munar-Qués M, Salva-Ladaria L, Mulet-Perera P, Sole M, Lopez-Andreu FR, Saraiva MJM. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid: Int. J. Exp. Clin. Invest. 7, 266–269 (2000).
   Google Scholar
• Haraoka K, Ando Y, Ando E et al. Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid:j Protein Folding Disord 9, 247–251 (2002).
   PubMed Web of Science ®Google Scholar
• Dubrey SW Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RII. Progression ofventricular wall thickening after liver transplantation for familial amyloidosis. 71/plantation 64, 74–80 (1997).
   Google Scholar
• Stangou AJ, Hawkins PN, Heaton ND et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy. Transplantation 66, 229–233 (1998).
   PubMed Web of Science ®Google Scholar
• Olofsson B-0, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 73, 745–751 (2002).
   Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell GG. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sc]. USA 87, 2843–2845 (1990).
   PubMed Web of Science ®Google Scholar
• Yazaki M, Tokuda T, Nakamura A eta/. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild type transthyretin. Biochem Biophys. Res. Commutz 274, 702–706 (2000).
   Google Scholar
• Brusilow SW, Horwich AL. Urea cycle enzymes. In: The Metabolic and Molecular Bases of Inherited Disease, 7th Edition. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA, 1187–1232 (1995).
   Google Scholar
• Saheki T, Kobayashi K, Inoue I. Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev Physiol Biochem. Pharmacol 108, 21–68 (1987a).
   Google Scholar
• Ikeda S, Yazaki M, Takei Y et al. Type II (adult onset) citrullinemia: clinical pictures and the therapeutic effect of liver transplantation. J. Neural Neurosurg. Pwchiatry 71, 663–670 (2001).
   PubMed Web of Science ®Google Scholar
• •First report that describes the detailed clinical pictures and therapeutic effect of liver transplantation in type II (adult onset) citrullinemia.
   Google Scholar
• Shiraki H, Yamamoto T, Yamada K, Shikata T An autopsied case of the 'pseudoulegyria type'of the hepatocerebral disease. Seishinshinkeishi 64, 305–318 (1962). (In Japanese)
   Google Scholar
• Oda M. Em n Beitrag zu den ldinischen und histopathologischen Problemen uber die hepatozerebralen Erkrankungen, isbesondere uber den 'Pseudoulegyrie Typ'. Seishinshinkeishi 65, 892–931 (1964). (In Japanese)
   Google Scholar
• Shiraki H, Oda M. Pseudoulegyric type of hepatocerebral disease. Naika 28, 491–498 (1971). (In Japanese)
   Google Scholar
• Tsuji T, Morita T, Matsuyama Y, Matsui T, Tamura M, Matsuoka Y. Sibling cases of chronic recurrent hepatocerebral disease with hypercitrullinemia. Gastroenterologia Japonica 11, 328–340 (1976).
   PubMedGoogle Scholar
• Saheki T, Ueda A, Hosoya Metal Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia. din. Chim. Acta. 109,325–335 (1981).
   PubMed Web of Science ®Google Scholar
• Saheki T, Ueda A, Hosoya M, Sase M, Nakano K, Katsunuma T Enzymatic analysis of citrullinemia (12 cases) in Japan. Adv. Exp. Med Bid 153, 63–76 (1982).
   Google Scholar
• Tomomasa T, Kobayashi K, Kaneko H et al. Possible clinical and histologic manifestations of adult-onset type II citrullinemia in early infancy. J. Pediatt: 138, 741–743 (2001).
   PubMed Web of Science ®Google Scholar
• Tazawa Y, Kobayashi K, Ohura T et al. Infantile cholestatic jaundice associated with adult-onset type II citrullinemia. Pediatn 138, 735–740 (2001).
   PubMed Web of Science ®Google Scholar
• Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J. Hum. Genet. 47, 333–341 (2002).
   Google Scholar
• Kobayashi K, Jackson MJ, Tick DB, O'Brien WE, Beaudet AL. Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. j Biol. Chem. 265, 11361–11367 (1990).
   Google Scholar
• Kobayashi K, Shaheen N, Terazono H, Saheki T Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia. Am. J. Hum. Genet. 55, 1103–1112 (1994).
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Shaheen N, Kumashiro R et al. A search for the primary abnormality in adult-onset type II citrullinemia. Am. J. Hum. Genet. 53, 1024–1030 (1993).
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Sinasac DS, Iijima M et al. The gene mutated in adult-onset type II citrullinemia encodes a putative mitochondrial carrier protein. Nature Genet. 22, 159–163 (1999).
   PubMed Web of Science ®Google Scholar
• Yasuda T, Yamaguchi N, Kobayashi K et al Identification of two novel mutations in the 5LC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum. Genet. 107, 537–545 (2000).
   Google Scholar
• Palmieri L, Pardo B, Lasorsa FM et al Citrin and aralarl are Ca2+-stimulated aspartate/glutamate transporters in mitochondria. EIVIBOJ 20, 5060–5069 (2001).
   PubMed Web of Science ®Google Scholar
• Takenaka K, Yasuda I, Araki H et al. Type II citrullinemia in an elderly patient treated with living related partial liver transplantation. Intern. Med. 39, 553–558 (2000).
   PubMed Web of Science ®Google Scholar
• Ishikawa F, Nakamuta M, Kato M et al Reversibility of serum NH3 level in a case of sudden onset and rapidly progressive case of type II citrullineimia. Internal. Med. 39, 925–929 (2000).
   Google Scholar
• Kobayashi K, Iijima M, Yasuda T et al Type II Citrullinemia (citrin deficiency): a mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein. In: Calcium: The Molecular Basis of Calcium Action in Biology and Medicine. Pochet R, Donato R, Haiech J, Heizmann C, Gerke V (Eds). Kluwer, The Netherlands, 565–587 (2000).
   Google Scholar
• Imamura Y, Kobayashi K, Shibatou T et al Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous 5LC25A13 mutation with and without the disease. Hepatol Res. 26, 68–72 (2003).
   PubMed Web of Science ®Google Scholar
• Ito T, Shiraki K, Sekoguchi K et al. Hepatocellular carcinoma associated with adult-type citrullinemia. Digest. Dis. Li. 45, 2203–2206 (2000).
   Web of Science ®Google Scholar
• Saheki T, Kobayashi K, Ichiki H etal. Molecular basis of enzyme abnormalities in urea cycle disorders: with special reference to citrullinemia and argininosuccinic aciduria. Enzyme 38, 227–232 (1987b).
   PubMedGoogle Scholar
• Kobayashi T, Nakata M, Terazono H, Shinsato T, Saheki T Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia. FEBS Lett. 372, 69–73 (1995).
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Horiuchi M, Saheki T Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25, 1160–1165 (1997).
   PubMed Web of Science ®Google Scholar
• Largilliere C, Houssin D, Gottrand F et al. Liver transplantation for ornithine transcarbamylase deficiency in a girl. Paediatrics 115, 415–417 (1989).
   Web of Science ®Google Scholar
• Mowat AP. Orthotopic liver transplantation in liver-based metabolic disorders. Eur Perliatr 151\(Suppl. 1) S32—S38 (1992).
   Google Scholar
• Jan D, Poggi F, Jouvet P et al Definitive cure of hyperammonemia by liver transplantation in urea cycle defects: report of three cases. 7iansplant Proc. 26,188 (1994).
   Google Scholar
• Saudubray JM, Touati G, Delonlay P et al Liver transplantation in urea cycle disorders. Eur. j Perliatr 158\(Suppl. 2), S55—S59 (1999).
   Google Scholar
• Todo S, Starzl TE, Tzakis A et al. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology15, 419–422 (1992).
   PubMed Web of Science ®Google Scholar
• Yazaki M, Ikeda S, Takei Y et al. Complete neurological recovery of an adult patient with type II citrullinemia after living related partial liver transplantation. Transplantation 62,1679–1681 (1996).
   PubMed Web of Science ®Google Scholar
• Kawamoto S, Strong RVV, Kerlin P et al. Orthotopic liver transplantation for adult-onset type II citrullinemia. Clin. Transplantation 11, 453–458 (1997).
   PubMed Web of Science ®Google Scholar
• Kasahara M, Ohwada S, Takeichi T et al Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. Transplantation 71, 157–159 (2001).
   PubMed Web of Science ®Google Scholar